Posterior chamber phakic intraocular lens (ICL) for hyperopia: Ten-year follow-up
Authors:
- Maria Pia GhiringhelloMGMaria Pia Ghiringhello
- Giuseppe Di MeglioGMGiuseppe Di Meglio
- Giordano FantonGFGiordano Fanton
- 1 September 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 33 (9) , 1579-1584
Abstract
To evaluate the long-term safety, efficacy, predictability, and stability of implantation of a Collamer implantable contact lens (ICL) (Staar) to correct hyperopic refractive errors. Ophthalmology Department, Santa Rita Hospital, Vercelli, Italy. Fifty-nine eyes of 34 patients with hyperopia had implantation of an ICL. Patients were examined preoperatively (baseline) and 1 day, 1 week, 1, 3, and 6 months, and 1, 2, 4, 6, 8, and 10 years postoperatively. Main outcome measures were subjective and objective refractions, uncorrected visual acuity, best corrected visual acuity (BCVA), variation in intraocular pressure (IOP), anterior chamber depth (ACD), variation in endothelial cells, adverse events, and patient satisfaction. Nine patients had ICL implantation in 1 eye and 25 patients, in both eyes. Preoperatively, the spherical equivalent (SE) was between +2.75 diopters (D) and +11.75 D and astigmatism was between +0.50 D and +1.00 D. The mean SE of the manifest refraction was +0.07 +/- 0.54 D; refraction stabilized quickly and remained stable throughout the follow-up period. At 10 years, the safety index was 111 and the efficacy index, 96.8. Of the eyes, 86.5% had a change in SE refraction within +/-0.50 D; 1.6% lost 1 Snellen line of BCVA. The mean endothelial cell loss was 4.7%, which remained almost unchanged throughout the follow-up period. The mean variation in ACD was -14.9% and in IOP, +5.3%. The results confirmed the long-term safety, efficacy, accuracy, and predictability of ICL implantation for hyperopia. The Collamer material was well tolerated in all eyes.Keywords
This publication has 9 references indexed in Scilit:
- United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopiaOphthalmology, 2004
- Comparison of Implantable Contact Lens and Laser Assisted In Situ Keratomileusis for Moderate to High MyopiaCornea, 2003
- U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopiaOphthalmology, 2003
- Phakic posterior chamber lenses for high myopia: Functional and anatomical outcomesJournal of Cataract & Refractive Surgery, 2000
- Cataract development after implantationof the Staar Collamer posterior chamber phakic lensJournal of Cataract & Refractive Surgery, 1999
- Staar Collamer posterior chamber phakic intraocular lens to correct myopia and hyperopiaJournal of Cataract & Refractive Surgery, 1998
- Posterior Chamber Phakic Intraocular Lens for Hyperopia of +4 to +11 DioptersJournal of Refractive Surgery, 1998
- Collamer intraocular contact lens to correct high myopiaJournal of Cataract & Refractive Surgery, 1996
- Clear lens extraction for the correction of high refractive errorJournal of Cataract & Refractive Surgery, 1994